Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $62.03 | $18.69 | 231.82% | 258.46x | 18.71x | 18.95x | 50.80x | 1.22x | $41.15M | 0.75% | $108.58M | 1.23 | $5.47B | 102.20 | ||
| CORT | CORCEPT THERAPEUTICS INC | $68.38 | $19.27 | 254.88% | 148.65x | 130.60x | 9.29x | 11.51x | 1.40x | $119.79M | 1.68% | $637.99M | 6.11 | $7.24B | -1,054.70 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $305.06 | $96.33 | 216.67% | 69.97x | 41.37x | 9.46x | 37.87x | 1.44x | $641.34M | 1.58% | $1.08B | 8.09 | $41.99B | 45.42 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $50.84 | $17.71 | 187.04% | 51.88x | 39.82x | 5.16x | 6.46x | 1.41x | $164.23M | 4.22% | $605.69M | 7.92 | $3.73B | 33.46 | ||
| KRYS | KRYSTAL BIOTECH INC | $310.30 | $97.81 | 217.24% | 40.04x | 38.38x | 21.78x | 7.16x | 1.90x | $237.38M | 2.61% | $1.28B | 43.59 | $8.66B | 40.45 | ||
| ADMA | ADMA BIOLOGICS INC | $7.93 | $10.72 | -26.04% | 11.49x | 7.99x | 3.67x | 4.71x | 0.39x | $107.90M | 5.76% | $390.33M | 1.65 | $1.90B | 8.57 | ||
| HALO | HALOZYME THERAPEUTICS INC | $68.18 | $72.10 | -5.44% | 23.03x | 8.23x | 5.34x | 36.82x | 0.42x | $667.65M | 8.29% | $219.64M | 1.86 | $9.92B | 15.90 | ||
| OMER | OMEROS CORP | $11.15 | $15.88 | -29.76% | 8.58x | -29.28x | 80.80x | -12.74x | 0.43x | -$94.78M | -11.82% | -$63.33M | -0.88 | $1.12B | 12.34 | ||
| RPRX | ROYALTY PHARMA PLC | $54.48 | $40.78 | 33.59% | 28.52x | 10.22x | 9.75x | 3.16x | 0.61x | $2.34B | 9.84% | $9.94B | 22.75 | $39.74B | 34.16 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.32 | $2.89 | 118.85% | 90.29x | 52.89x | 3.42x | 83.86x | 0.86x | $47.52M | 4.41% | $13.01M | 0.08 | $1.24B | 23.17 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.40 | $16.63 | -31.44% | 5.56x | 24.26x | 5.44x | 3.27x | 0.70x | $56.42M | 8.47% | $205.80M | 3.52 | $579.46M | 4.01 | ||
| VCEL | VERICEL CORP | $34.24 | $9.34 | 266.51% | 79.63x | 71.02x | 5.95x | 4.91x | 1.67x | $47.49M | 2.73% | $356.23M | 7.02 | $1.73B | 42.90 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $52.74 | $41.75 | 26.31% | 37.67x | 13.27x | 3.13x | 1.64x | 0.53x | $767.06M | 7.56% | $6.21B | 32.27 | $8.55B | 17.72 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $234.66 | $97.85 | 139.82% | 29.70x | 26.04x | 17.00x | 4.72x | 1.46x | $122.22M | 2.62% | $997.32M | 50.16 | $5.04B | 22.34 | ||
| ASND | ASCENDIS PHARMA A | $237.47 | $85.66 | 177.22% | 25.17x | 19.12x | 14.48x | 25.69x | 2.34x | $52.94M | 0.36% | $574.09M | 9.24 | $15.13B | 162.25 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $235.38 | $49.85 | 372.22% | 500.81x | 9.12x | 3.28x | 3.26x | 1.71x | $1.30B | 8.91% | $4.53B | 73.22 | $18.33B | 27.15 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.90 | $5.86 | -50.55% | 10.74x | 4.24x | 2.72x | 3.17x | 0.23x | $7.24M | 4.34% | $52.93M | 0.92 | $114.26M | 7.37 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $31.49 | $36.66 | -14.11% | 12.45x | 8.58x | 2.03x | 2.00x | 0.47x | $341.79M | 18.77% | $910.35M | 15.75 | $1.39B | 5.88 | ||
| TECH | BIO-TECHNE CORP | $50.84 | $15.73 | 223.14% | 71.61x | 25.86x | 6.56x | 3.82x | 1.47x | $269.60M | 3.39% | $2.09B | 13.34 | $8.04B | 31.41 | ||
| TGTX | TG THERAPEUTICS INC | $38.82 | $19.04 | 103.89% | 12.06x | 25.86x | 8.01x | 10.19x | 7.89x | -$14.19M | -0.25% | $583.13M | 4.04 | $6.25B | 41.67 | ||
| UTHR | UNITED THERAPEUTICS CORP | $562.09 | $252.92 | 122.24% | 19.20x | 19.34x | 7.71x | 4.04x | 2.03x | $1.02B | 4.16% | $5.90B | 135.66 | $22.58B | 13.18 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.84 | $2.51 | 52.69% | 16.00x | 16.23x | 2.35x | 3.71x | 1.08x | $4.11M | 1.33% | $82.33M | 1.03 | $241.86M | 11.39 | ||
| EXEL | EXELIXIS INC | $51.45 | $31.54 | 63.13% | 16.49x | 15.62x | 5.59x | 6.68x | 1.20x | $917.69M | 6.90% | $1.94B | 7.49 | $12.88B | 12.19 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.29 | $15.23 | 105.40% | 17.29x | 16.27x | 6.41x | 3.78x | 1.96x | $208.13M | 5.44% | $1.01B | 8.28 | $3.08B | 9.18 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.10 | $1.78 | 17.93% | 11.05x | 9.67x | 2.19x | 2.52x | 0.95x | $13.00M | 7.76% | $67.23M | 0.84 | $135.97M | 6.09 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $621.52 | $452.85 | 37.25% | 14.60x | 13.14x | 4.33x | 2.07x | 0.96x | $4.11B | 6.36% | $31.42B | 302.15 | $64.90B | 11.30 | ||
| MDXG | MIMEDX GROUP INC | $3.67 | $1.60 | 129.85% | 17.48x | -51.40x | 1.40x | 2.25x | 2.71x | $69.36M | 12.72% | $242.94M | 1.64 | $404.45M | 7.42 | ||
| VCYT | VERACYTE INC | $47.99 | $12.62 | 280.38% | 43.23x | 42.64x | 7.05x | 2.85x | 2.48x | $155.34M | 4.07% | $1.34B | 16.90 | $3.60B | 31.32 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $447.97 | $173.56 | 158.11% | 26.34x | 22.90x | 9.32x | 5.87x | 1.88x | $3.71B | 3.26% | $19.36B | 76.20 | $110.19B | 20.43 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.30 | $4.70 | 267.76% | 28.83x | 4.96x | 0.83x | 1.21x | 4.04x | $109.24M | 6.01% | $1.51B | 14.34 | $2.40B | 28.99 | ||
| INCY | INCYTE CORP | $97.50 | $67.63 | 44.16% | 13.37x | 12.38x | 3.63x | 3.46x | 1.18x | $1.45B | 7.46% | $5.62B | 28.21 | $16.05B | 8.58 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.